Brucella “Hitches a Ride” with Autophagy  by Brumell, John Hunter
Cell Host & Microbe
Previews(i.e., ready-to-go) state of the expressed
var gene locus.
Proteomics studies of proteins associ-
ated with iNPE and PfSET10 also identify
a variety of RNA-binding proteins. The
importance and specificity of these
proteins for var expression are not yet
known, but given the still mysterious but
ubiquitous sterile transcripts driven by
the bidirectional promoter within the
intron of var genes (Epp et al., 2009), one
can speculate a role for these RNA-
binding proteins in regulation of noncod-
ing RNA involved in maintenance of the
heterochromatin structure of the silenced
var loci or regulation of the stability of the
expressed var mRNA.
A lingering question is how and when
these specialized nuclear structures are
assembled and maintained. Early studies
indicated that the critical processes that
govern var gene activation and silencing
occur during S phase, when chromatin is
reorganized during the processes of
DNA replication, histone deposition, and
nuclear division (Deitsch et al., 2001).
Inheritance of nuclear spatial structure
may also be another mechanism by which
the epigenetic information governing var
gene expression is bestowed during the
process of schizogeny. Actin was also
identified by Volz et al. as coprecipitating
with PfSET10, so actin may be important2 Cell Host & Microbe 11, January 19, 2012 ªfor recruitment, maintenance, or tethering
the chromatin complexes in the active var
expression site.
We now have an improved under-
standing of var gene activation and
silencing, but many questions remain.
While var localization within heterochro-
matin clusters appears necessary for
silencing, it is not clear how a silenced
var locus transitions from heterochro-
matin to a euchromatin nuclear region
competent for var expression. Other
modifying enzymes such as lysine deme-
thylases should be in play, but the identity
and location of these other factors
remains a mystery. It is possible that var
loci are active by default unless they are
sequestered into heterochromatin, but
the unique localization of PfSET10 argues
that there are dedicated effectors that act
in a specialized transcriptional zone to
achieve variant gene expression. Stay
tuned for further insights into the var
variations.
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Autophagy involves lysosomal-mediated degradation of cellular components and contributes to host immu-
nity. Some pathogens avoid autophagy-mediated killing, while others exploit it to acquire host cell nutrients.
Starr et al. reveal that the intracellular bacterial pathogen Brucella abortus can ‘‘hitch a ride’’ with autophagy,
subverting autophagy machinery to spread from cell to cell (Starr et al., 2012).Bacteria in the genus Brucella are the
causative agent of brucellosis, a world-
wide zoonosis. The bacteria are trans-
mitted by consumption of infected
food, animal contact, or inhalation of
aerosols. While Brucella can survive inthe environment to promote transmis-
sion, these bacteria can only replicate
within host cells during an infection. As
such, there is great interest in under-
standing the intracellular life cycle of
these bacteria.During infection of a host, Brucella
infects many cell types, including profes-
sional phagocytes. Delivery of bacterial
virulenceproteins intohostcells viaadedi-
cated translocation system, the VirB type
IV secretion system, allows the bacteria
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Previewsto subvert cellular machinery and colonize
a vacuolar compartment, the Brucella-
containing vacuole (BCV), within host
cells. Previous studies had shown that
BCVs can traffic along the endocytic
pathway during the first 8 hr of infection.
These endosomal BCVs (eBCVs) undergo
limited fusion with late endosomal/lyso-
somal compartments, though this is not
capable of killing the bacteria (Starr et al.,
2008). Expression of the VirB secretion
system directs BCVs toward the endo-
plasmic reticulum (ER) in a Sar1- and
Rab2-dependent manner (Celli et al.,
2005; Fugier et al., 2009). Fusion of ER
with BCVs generates a replication-
permissive compartment, referred to by
the authors as the replicative BCV
(rBCV).Whilemuch focushasbeenplaced
on these stages of infection that allowed
Brucella to establish a replicative niche in
host cells, little attention was paid to later
stages of infection. And while cell-to-cell
spread is recognized as an essential step
in microbial infection (Hybiske and Ste-
phens, 2008), the mechanism(s) used by
Brucella to perpetuate infection in its
host were unknown.
In this issue of Cell Host & Microbe,
Starr et al. characterize the postreplica-
tion stages of B. abortus infection in
macrophages and epitheloid cells. At the
onset of their study, they observed that
a population of bacteria acquires the lyso-
some-associated membrane protein-1
(LAMP-1) beginning after 48 hr of infec-
tion. This was surprising, since LAMP-1
is a marker of the early eBCV stage, but
is subsequently lost in the rBCV stage
when the bacteria begin to replicate. The
LAMP-1+ BCVs at late stages of infection
were large, contained multiple bacteria,
and lacked the ER marker calreticulin,
indicating they were not rBCVs. Using an
inducible GFP reporter, Starr et al.
showed that the late LAMP-1+ BCVs con-
tained viable and transcriptionally active
bacteria, indicating these were not degra-
dative phagolysosomes. So what are
these compartments?
The authors use electron microscopy
techniques to confirm that the late
LAMP-1+ BCVs are not ribosome-laden
rBCVs but rather compartments delimited
by double-membrane crescents or mul-
tiple membranes, reminiscent of autopha-
gosomes containing bacteria that were
observed in previous studies (Shahnazari
and Brumell, 2011). They termed thesecompartments autophagic BCVs (aBCVs)
and proceeded to characterize themolec-
ular machinery required for their formation
from rBCVs.
There are many autophagy pathways
for delivery of cellular cargo to the lyso-
some (Levine et al., 2011). The macroau-
tophagy pathway involves the formation
of double-membrane autophagosomes
containing cargo and requires a group of
more than 31 ‘‘Atg’’ proteins conserved
from yeast to man. These Atg proteins
act at various stages of the macroautoph-
agy pathway. A complex including Atg1
(ULK-1 inmammals) kinase regulates initi-
ation of the pathway. Atg6 (Beclin 1 in
mammals) coordinates a complex with
Atg14L and the class III PI3K VPS34 to
generate phosphoinositide signals that
promote autophagosome formation.
Elongation of the nascent autophago-
some around cellular cargo requires two
conjugation reactions involving the ubiq-
uitin-like molecules Atg12 and Atg8
(LC3 is a homolog in mammals). Of note,
Atg8/LC3 is conjugated to phosphatidyl-
ethanolamine during macroautophagy
and serves as a marker for autophago-
somes for most studies of autophagy.
Starr et al. explored the role of auto-
phagy components in the generation of
aBCVs via knockdown/knockout ap-
proaches. Surprisingly, they found that
the macroautophagy initiation factors
ULK-1, Beclin 1, and ATG14 are required
for aBCV formation, but not the elongation
factors ATG5, ATG16L1, ATG4B, ATG7,
and LC3B. In support of their genetic
studies, the macroautophagy marker
LC3 is not observed on aBCVs. This indi-
cates that Brucella selectively co-opts
some macroautophagy components, but
not others, to generate aBCVs.
This opens the question of how aBCVs
canacquire themorphologyof amacroau-
tophagosome without the elongation
machinery normally required to generate
these structures. In fact, there is evidence
of a ‘‘noncanonical’’ macroautophagy
pathway that does not require the elonga-
tion machinery of macroautophagy and
does not acquire the marker LC3B (Nish-
ida et al., 2009). Nishida et al. showed
that in response to DNA damage (etopo-
side treatment), double-membrane mac-
roautophagosomes form in the absence
of either Atg5 or Atg7. Macroautophago-
somes containing bacteria have been
observed in the absence of Atg5 (CollinsCell Host & Microbeet al., 2009), indicating that this ‘‘nonca-
nonical’’ macroautophagy pathway plays
a significant role in host-pathogen interac-
tions. Starr et al. extend these observa-
tions, providing evidence that both the
‘‘canonical’’ and ‘‘noncanonical’’ macro-
autophagy pathways have common
upstream regulators, an important obser-
vation with far-reaching implications.
This insight will allow genetic dissection
of the components required for ‘‘nonca-
nonical’’ macroautophagy. Furthermore,
Starr et al. show that bacteria can
exploit this pathway during infection of
host cells.
What is the consequence of aBCV
formation? As mentioned above, these
structures have late-endosomal/lyso-
somal features, but do not appear to
degrade the bacteria. Instead, the authors
find that aBCV formation is associated
with cell-to-cell spread. It is remarkable
that a pathway associated with the degra-
dation of cellular components can be ex-
ploited by a bacterial pathogen for
dissemination within its host. Is the ‘‘non-
canonical’’ macroautophagy pathway
specifically exploited for cell-to-cell
spread? Possibly, though it was shown
that poliovirus can undergo nonlytic cell-
to-cell spread in a manner dependent on
the autophagy elongation factors ATG12
and LC3, which are required for ‘‘canon-
ical’’ macroautophagy (Jackson et al.,
2005). How do aBCVs mediate cell-to-
cell spread? Is there an extracellular inter-
mediate, or are the bacteria shuttled
between cells along cellular connections
such as nanotubular networks? Many
questions remain about how Brucella
exploits macroautophagy components
to complete its life cycle. Whether this
pathway is similarly utilized by other
bacterial pathogens will also be an
exciting area of future research.REFERENCES
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During acute cystitis, uropathogenic Escherichia coli (UPEC) induce bladder epithelial cell exfoliation, which
eliminates infected cells and promotes UPEC dissemination. Dhakal and Mulvey (2012) uncover the mecha-
nism that induces this exfoliation and reintroduce the pore-forming toxin, hemolysin, as an effector that
surprisingly targets multiple host pathways to facilitate infection.Detailed models of epithelial infection
using uropathogenic Escherichia coli
(UPEC) have redefined intracellular path-
ogen lifestyles, bacterial suppression of
host responses, and pathogen influences
on cellular and developmental programs
within epithelial tissues. Upon introduc-
tion into the urinary bladder, UPEC bind
epithelial surfaces via an array of adhesive
surface structures and gain access to the
intracellular environment. Cell entry likely
leverages the normal membrane-recy-
cling activity of superficial bladder epithe-
lial cells (BECs) that is required for accom-
modation of changing urine volume
(Bishop et al., 2007). Studies by Mulvey’s
group and others have shown that Rho
family GTPases and modulation of actin
dynamics figure prominently in UPEC
entry and may affect the downstream
fate of internalized bacteria (Dhakal
et al., 2008). A subset of these organisms
then proliferate to form large cohesive
colonies termed intracellular bacterial
communities (IBCs). Numerous studies
suggest that these IBCs represent a haven
for pathogen multiplication, protected
from the activity of neutrophils and mac-rophages that are the primary cellular
defenders against mounting infection.
The outcome of a complicated conversa-
tion between UPEC and the mammalian
host, this UPEC developmental pathway
is certainly driven by stepwise and con-
certed expression of a number of families
of virulence determinants.
A consistent feature of acute cystitis,
a urinary tract infection (UTI) most often
caused by UPEC, in both mice and hu-
mans is the exfoliation of superficial
BECs (Mulvey et al., 1998), accompanied
by activation of host cell differentiation
programs that normally run much more
slowly (Mysorekar et al., 2009). On one
hand, the discharge of infected BECs
into the urine can certainly be viewed as
an important host defense mechanism,
a way for the infected organ to rid itself
of perhaps 100,000 bacteria in a single
event. However, this process exposes
the underlying transitional cells to UPEC,
which can subsequently establish nests
of quiescent bacteria that resist antibi-
otic therapy, avoid detection by immune
effectors, and seed recurrent UTI. Mulvey
was first to report the exfoliation of BECsin response to infection (Mulvey et al.,
1998), and now his group reports the first
molecular details underlying exfoliation
and the bacterial effector that drives this
process (Dhakal and Mulvey, 2012).
UPEC liberates a number of toxins,
including hemolysin and cytotoxic necro-
tizing factor-1, to optimize the host envi-
ronment for propagating infection. Unlike
some of its enteric relatives, UPEC fore-
goes the need for a dedicated contact-
dependent secretion apparatus to inject
manipulative proteins into the host cell.
During cystitis, the simple residence of
this pathogen within the host cell cyto-
plasm permits the delivery of an array of
highly active molecules. E. coli hemolysin
(encoded by the hlyCABD operon) is
a prototypic repeat-in-toxin (RTX) mole-
cule and an important model for acylation
of virulence factors within the bacterial
cytoplasm. The protoxin (HlyA) is modi-
fied by the acyltransferase HlyC in a step
required for cytotoxic activity, and export
is accomplished by the action of inner
membrane components HlyB and HlyD
along with the outer membrane protein
TolC (reviewed in Welch, 2005). At high
